Literature DB >> 14520505

Reversible acute renal failure after unilateral extracorporeal shock-wave lithotripsy.

Giovanni Liguori1, Carlo Trombetta, Stefano Bucci, Leonardo Salamè, Silvana Savoldi, Emanuele Belgrano.   

Abstract

Extracorporeal shock-wave lithotripsy (ESWL) is the treatment of choice for the majority of patients with renal or proximal ureteral stones. We describe an unusual case of anuric renal failure following ESWL, in absence of obstruction or myoglobinuria, in the presence of unilateral nephrolithiasis and two normally functioning kidneys. A mechanism for this patient's acute renal failure (ARF) is postulated. Although the frequency of ARF after ESWL is extremely rare and the mechanism responsible for ARF is not understood, the appearance of ARF, when ureteral obstruction or hematoma are absent, should be included among complications following EWSL. Attention should be paid to older patients.

Entities:  

Mesh:

Year:  2003        PMID: 14520505     DOI: 10.1007/s00240-003-0369-3

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  10 in total

Review 1.  Neural control of renal function.

Authors:  G F DiBona; U C Kopp
Journal:  Physiol Rev       Date:  1997-01       Impact factor: 37.312

2.  Bilateral acute tubular necrosis after unilateral extracorporeal shock-wave lithotripsy.

Authors:  D Kleinknecht; J L Pallot; P Chauveau
Journal:  Nephron       Date:  1994       Impact factor: 2.847

3.  Acute renal failure associated with intramuscular ketorolac.

Authors:  K Smith; R M Halliwell; S Lawrence; P L Klineberg; P O'Connell
Journal:  Anaesth Intensive Care       Date:  1993-10       Impact factor: 1.669

4.  Effects of extracorporeal shock wave lithotripsy to one kidney on bilateral glomerular filtration rate and PAH clearance in minipigs.

Authors:  L R Willis; A P Evan; B A Connors; G Reed; N S Fineberg; J A Lingeman
Journal:  J Urol       Date:  1996-10       Impact factor: 7.450

5.  Anuric renal failure from massive bilateral renal hematoma following extracorporeal shock wave lithotripsy.

Authors:  A K Tuteja; J P Pulliam; T H Lehman; L W Elzinga
Journal:  Urology       Date:  1997-10       Impact factor: 2.649

Review 6.  Experimental basis of shockwave-induced renal trauma in the model of the canine kidney.

Authors:  J Rassweiler; K U Köhrmann; W Back; S Fröhner; M Raab; A Weber; F Kahmann; E Marlinghaus; K P Jünemann; P Alken
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Acute morphological changes in canine kidneys after exposure to extracorporeal shock waves. A light and electron microscopic study.

Authors:  S J Karlsen; B Smevik; T Hovig
Journal:  Urol Res       Date:  1991

Review 8.  The role of lithotripsy and its side effects.

Authors:  J E Lingeman; J Woods; P D Toth; A P Evan; J A McAteer
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

9.  Age-related changes in resistive index following extracorporeal shock wave lithotripsy.

Authors:  R Knapp; F Frauscher; G Helweg; D zur Nedden; H Strasser; G Janetschek; G Bartsch
Journal:  J Urol       Date:  1995-09       Impact factor: 7.450

10.  Effects of extracorporeal shock wave lithotripsy on plasma concentrations of endothelin and renin in humans.

Authors:  W L Strohmaier; A M Carl; D M Wilbert; K H Bichler
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

  10 in total
  3 in total

1.  Impact of stone removal on renal function: a review.

Authors:  Kyle Wood; Tristan Keys; Patrick Mufarrij; Dean G Assimos
Journal:  Rev Urol       Date:  2011

2.  Treatment of renal calculi by lithotripsy: minimizing short-term shock wave induced renal damage by using antioxidants.

Authors:  Khaleel A Al-Awadi; Elijah O Kehinde; Issa Loutfi; Olusegun A Mojiminiyi; Adel Al-Hunayan; Hamdy Abdul-Halim; Ahmed Al-Sarraf; Anjum Memon; Mathew P Abraham
Journal:  Urol Res       Date:  2007-12-07

Review 3.  [Ureteral stricture after extracorporeal shock wave lithotripsy. Case report and overview of the spectrum of rare side effects of modern ESWL treatment].

Authors:  F Finter; L Rinnab; J Simon; B Volkmer; R Hautmann; R Kuefer
Journal:  Urologe A       Date:  2007-07       Impact factor: 0.803

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.